EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Fibrosis-driven hepatocarcinogenesis, metastasis and immune evasion: Mechanisms and therapeutic targets

Zilong Zhang, Xiaoping Chen, Bixiang Zhang, Wanguang Zhang, Ze-Yang Ding, Expert Group on Portal Hypertension of the Chinese College of Surgeons (CCS), Chinese Medical Doctor Association (CMDA)

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2026

DOI: 10.1016/j.bbcan.2025.189517 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2026. Verfasst von Zilong Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hepato-Pancreato-Biliary Surgery, Clinical Medical Research Center of Hepatic Surgery at Hubei Province, and Hubei Key Laboratory of Hepa…. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Liver Cirrhosis, Immune Evasion. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 235 Literaturangaben. Gefördert von: Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan Municipal Health Commission, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) arising on a background of fibrosis has fundamental mechanistic and clinical differences compared to HCC that arises in a non-fibrotic liver. The fibrotic microenvironment is characterized by extracellular matrix (ECM) remodeling, dynamic interactions with immune and stromal cells, and activation of hepatic stellate cells (HSCs) and cancer-associated fibroblasts (CAFs). Recent multi-omics analyses have demonstrated that these fibrotic niches dynamically promote hepatocarcinogenesis, metastasis and immune evasion. Several therapeutic strategies targeting fibrosis have improved HCC outcomes in clinical trials. These advances have facilitated an understanding of the complex mechanisms underlying fibrosis-driven HCC and are helping to optimize therapeutic prescriptions. This review synthesizes recent advances in understanding the role of fibrosis in hepatocarcinogenesis, aggressiveness, and metastasis; decodes how stromal-immune crosstalk defines immune escape through the fibrosis-driven '3C' immune evasion framework; and links mechanistic insights into fibrosis-driven HCC with emerging theranostic strategies. We emphasize that targeting fibrosis-driven oncogenic mechanisms may enhance the therapeutic efficacy in HCC, thus providing a scientific foundation for rationalizing this approach as a viable strategy against both liver fibrosis and HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsCarcinoma, HepatocellularLiver CirrhosisImmune EvasionHumansTumor MicroenvironmentHepatic Stellate CellsAnimalsCarcinogenesisNeoplasm MetastasisTumor EscapeExtracellular MatrixCancer-Associated Fibroblasts

Stichwörter der Autor:innen

Cancer-associated fibroblastsFibrosisHepatocellular carcinomaImmune evasionNanomedicine

Autor:innen und Institutionen

  • Division of Hepato-Pancreato-Biliary Surgery, Clinical Medical Research Center of Hepatic Surgery at Hubei Province, and Hubei Key Laboratory of Hepato-Pancreatic-Biliary Diseases, Tongji Hospital, Tongji Medical Colleg…

Förderung

  • Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology
  • Wuhan Municipal Health Commission
  • National Natural Science Foundation of China
  • Huazhong University of Science and Technology

Zitieren

APA

Zhang, Z., Chen, X., Zhang, B., Zhang, W., Ding, Z. Y., Expert Group on Portal Hypertension of the Chinese College of Surgeons (CCS), & Chinese Medical Doctor Association (CMDA) (2026). Fibrosis-driven hepatocarcinogenesis, metastasis and immune evasion: Mechanisms and therapeutic targets. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. https://doi.org/10.1016/j.bbcan.2025.189517

Vancouver

Zhang Z, Chen X, Zhang B, Zhang W, Ding ZY, Expert Group on Portal Hypertension of the Chinese College of Surgeons (CCS), et al. Fibrosis-driven hepatocarcinogenesis, metastasis and immune evasion: Mechanisms and therapeutic targets. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2026. doi:10.1016/j.bbcan.2025.189517

BibTeX
@article{Zhang2026,
  author = {Zhang, Zilong and Chen, Xiaoping and Zhang, Bixiang and Zhang, Wanguang and Ding, Ze-Yang and Expert Group on Portal Hypertension of the Chinese College of Surgeons (CCS), Expert Group on Portal Hypertension of the Chinese College of Surgeons (CCS) and Chinese Medical Doctor Association (CMDA), Chinese Medical Doctor Association (CMDA)},
  title = {Fibrosis-driven hepatocarcinogenesis, metastasis and immune evasion: Mechanisms and therapeutic targets},
  journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
  year = {2026},
  doi = {10.1016/j.bbcan.2025.189517}
}
Kostenlos starten →